|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The 70-gene signa- ture as a response predictor for neoadjuvant chemotherapy in breast cancer 显示文摘 | Strayer ME Glas AM Hannemann J | 2010 | Breast Cancer Res Treat2010，119，3： | 1 |
| 2 | Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial显示文摘 | Strayer ME Meijnen P van Tienhoven G | 2010 | VeronAnn Surg Onco12010，17，7： | 1 |
| 3 | Sentinel node identification rate and nodal involvement in the EORTC 10981- 22023 AMAROS trial 显示文摘 | Strayer ME Meijnen P van Tienhoven G | 2010 | Ann Surg Oncol2010，17，7： | 1 |
| 4 | Feasibi|ity of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients 显示文摘 | Strayer ME Aukema TS O|mos RA | 2010 | Eur J Nucl Med Mol Imaging2010，37，6： | 1 |
| 5 | The 70 - gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer 显示文摘 | Strayer ME Glas AM Hannemann J | 2010 | Breast Cancer Res Treat2010，119，： | 1 |
| 6 | Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer ( EORTC 10981-22023AMAROS ) : randomised, multicenter, open-label, phase 3 non-inferiority trial 显示文摘 | Donker M van Tienhoven G Strayer ME | 2014 | Lancet Oncol2014，15，12： | 1 |
| 7 | Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer显示文摘 | Strayer ME Meijnen P van Tienhoven G | 2010 | J Clin Oncol2010，28，5： | 1 |
| 8 | Sentinel node i- dentification rate and nodal involvement in the EORTC 10981- 22023 AMAROS trial显示文摘 | Strayer ME Meijnen P van Tienhoven G | 2010 | Ann Surg Oncol2010，17，7： | 1 |
| 9 | Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial显示文摘 | Strayer ME Meijnen P van Tienhoven G | 2010 | Ann Surg Oneol2010，17，7： | 1 |
| 10 | Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy 显示文摘 | Strayer ME van Adrichem JC Rutgers E J | 2008 | Ned Tijdschr Geneeskd2008，152，46： | 1 |
| 11 | Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients显示文摘 | Strayer ME Aukema TS Olmos RA | 2010 | Eur J Nucl Med Mol Imaging2010，37，6： | 1 |
| 12 | The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer显示文摘 | Strayer ME Glas AM Hannemann J et el | 2010 | Breast Cancer Res Treat2010，119，： | 1 |
| 13 | Sentinel node identification rate and nodal involvement in the E- ORTC 10981-22023 AMAROS trial显示文摘 | Strayer ME Meijnen P Van Tienhoven G | 2010 | Ann Surg Oncol2010，，17： | 1 |
| 14 | Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial显示文摘 | Strayer ME Meijnen P Tienhoven G | 2010 | Ann Surg Oncol2010，17，4： | 1 |
| 15 | Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer ( EORTC 10981-22023 AMAROS) : a randomised, multieentre, open-label, phase 3 non-inferiority trial 显示文摘 | Donker M van Tienhoven G Strayer ME | 2014 | Lancet Oncol2014，15，12： | 1 |
| 16 | Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer ( EORTC 10981-22023 AMAROS) : a randomised, multicentre, open-label, phase 3 non-inferiorlty trial 显示文摘 | Donker M van Tienhoven G Strayer ME | 2014 | Lancet Oncol2014，15，12： | 1 |
| 17 | Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy 显示文摘 | Strayer ME Rutgers EJ Oldenburg HS | 2009 | Am J Sury2009，198，1： | 1 |
| 18 | Radiotherapy or sur- gery of the axi显示文摘 | Perou CM ven G Strayer ME | 2000 | Nature2000，406，6797： | 1 |
| 19 | Maguetic resonance hnag- ing response monitoring of breast cancer during neoadjuvant che- motherapy: relevance of breast cancer subtype显示文摘 | Loo CE Strayer ME Rodenhuis S | 2011 | J Clfil Oncol2011，29，6： | 1 |
| 20 | Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS) : a randomised, multicentre, open-label, phase 3 non-inferiority trial 显示文摘 | Donker M van Tienhoven G Strayer ME | 2014 | Lancet Oncol2014，15，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员